Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
Author(s): Leighton MP, Lam C, Mehta S, Spiller RC
Trials. 2013 Jan 9;14.
NIHR Acknowledged: No
|Professor Robin Spiller||Professor Spiller is Professor of Gastroenterology in the NIHR Nottingham Biomedical Research Centre at the University of Nottingham. Past Editor of Gut (2003-2009) and member of the Board of the Rome Foundation (2000-2015), he twice edited the…|